Tandem Diabetes Stock After Hours
Over the last 12 months, tandem diabetes care's shares have ranged in value from as little as $76.19 up to $143.67. The company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim x2 insulin delivery system (t:slim x2), and.
February 24, 2021 by sean whooley.
Tandem diabetes stock after hours. 13, 2019 at 7:14 a.m. Beta is a measure of a share's volatility in relation to the market. Image by luann hunt from pixabay.
The firm has three key insulin pump products. Shares of tndm were up 12.9% at $103.04 per share after the market closed. The stock has rallied 47.6% since its.
Shares of tandem diabetes care, inc. View statistical stock analysis for tandem diabetes care (tndm). Access our live streaming chart for the tandem diabetes care inc stock, free of charge.
Tndm shares were down 12.3% at $124.01 per share. Tandem diabetes care started at outperform with $83 stock price target at svb leerink marketwatch. Tandem diabetes care started at outperform with $83 stock price target at svb leerink.
Tandem diabetes care upgraded to buy from neutral at ubs marketwatch. (tndm) stock rallied over 1.65% intraday to trade at $129.28 a share on nasdaq. A popular way to gauge a stock's volatility is its beta.
Nvo) number of hedge fund holders: The company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim x2 insulin delivery system (t:slim x2), and its product offerings. +2.42 (+1.81%) data as of oct 29, 2021.
The t:flex insulin delivery system is used by customers with greater insulin needs. Its flagship product, t:slim x2 insulin delivery. Common stock (tndm) nasdaq listed.
The t:slim insulin delivery system can easily fit into a user's pocket. The stock market’s reaction to this one word from the fed’s powell shows investors should be careful. The market (nasdaq average) beta is 1, while tandem diabetes care's is 0.214.
Is a medical device company. Tndm), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended september 30, 2021 and updated its sales guidance for the year ending december 31, 2021. Is a medical device company.
Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large percentage moves and block trades. Data is currently not available. Best diabetes stocks to buy now.
Post a Comment for "Tandem Diabetes Stock After Hours"